Clinical trial
Effects of Oral Salmon Calcitonin in Human Osteoarthritis
NCT00376311 · Université Catholique de Louvain, Other · Terminated
Key facts
| NCT number | NCT00376311 |
|---|---|
| Title | Effects of Oral Salmon Calcitonin in Human Osteoarthritis |
| Official title | Phase IIa Study of the Effects of a New Oral Formulation of Salmon Calcitonin in Human Osteoarthritis |
| Lead sponsor | Université Catholique de Louvain, Other |
| Collaborators | Novartis Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | oral salmon calcitonin |
| Enrollment | 54 |
| Start date | Sep 1, 2002 |
| Completion | May 1, 2004 |
| First posted | Sep 14, 2006 |
| Last update posted | Sep 14, 2006 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: